Adam J Friedman, Valerie Foy, Daniel L Fischer, Nicole Tilin, Graham Litchman
Journal: Journal of drugs in dermatology : JDD 2024;23(12):1108-1113
PMID: 39630682
Many dermatologic medications have the potential to induce ocular complications. Traditional medications, including corticosteroids, retinoids, antibiotics, antihistamines, and immunosuppressants, have been associated with eye dryness, irritation, allergy, infection, atrophy, pigmentary changes, increased intraocular pressure, and impaired vision. Novel therapeutic agents such as biologics raise new concerns for ocular surface disease and conjunctivitis. Dermatologists should recognize these oculocutaneous side effects for appropriate decision-making, coordinating interdisciplinary care, and optimizing patient outcomes. J Drugs Dermatol. 2024;23(12):1108-1113. doi:10.36849/JDD.8236.
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.